Featured Research

from universities, journals, and other organizations

Genetic differences in female athletes with ACL injuries found in study

Date:
March 13, 2014
Source:
American Academy of Orthopaedic Surgeons
Summary:
For the first time, a new study identified varied female-to-male expression of ribonucleic acid molecules leading to proteins maintaining ligament structure, that could explain why females are more likely to suffer an anterior cruciate ligament injury than males.

Female athletes are two-to-eight times more likely to suffer an anterior cruciate ligament (ACL) injury than males. And while there has been speculation on possible anatomic, hormonal and neuromuscular factors that may place females at greater risk for these injuries, little research has looked specifically at the role of genetics.

For the first time, a new study identified varied female-to-male expression of ribonucleic acid (RNA) molecules leading to proteins maintaining ligament structure.

In the study, "Gene Expression Differences in Young Male and Female Ruptured Anterior Cruciate Ligaments," a biopsy of normally discarded ruptured ACL tissue was obtained during surgery from seven male and seven female young athlete patients. Biopsies were then divided into groups for microscopic (histological) and genetic analysis. Thirty-two significantly differentially expressed genes were isolated from male and female tissue, of which 14 were neither linked to the X or Y chromosome.

The 14 remaining genes were then grouped according to skeletal muscular development, function and cellular growth. In females, compared to males, the microarray analysis showed altered responses in signaling pathways that regulate cartilage and tissue growth.

The study authors believe the findings represent "the tip of the iceberg" in terms of determining the role of genetics in ACL structure and tendency toward increased ligament injury in female compared to male athletes.

Abstract to the presentation on this research can be found at: http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=3358&sKey=47b6cfe1-82d8-4509-9b33-7f7473c13f0d&cKey=22499357-aa6a-42e8-9107-ba8e78b71386&mKey=4393d428-d755-4a34-8a63-26b1b7a349a1


Story Source:

The above story is based on materials provided by American Academy of Orthopaedic Surgeons. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Orthopaedic Surgeons. "Genetic differences in female athletes with ACL injuries found in study." ScienceDaily. ScienceDaily, 13 March 2014. <www.sciencedaily.com/releases/2014/03/140313092609.htm>.
American Academy of Orthopaedic Surgeons. (2014, March 13). Genetic differences in female athletes with ACL injuries found in study. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/03/140313092609.htm
American Academy of Orthopaedic Surgeons. "Genetic differences in female athletes with ACL injuries found in study." ScienceDaily. www.sciencedaily.com/releases/2014/03/140313092609.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins